ROBINS CHAD M (CEO and Chairman) sold 5.2% of their position (120.59K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $1.77M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/8/2026ACC: 0001780649-26-000011
DirectorOfficer· CEO and Chairman
Since Jun 2019
-120.59K
Net shares
Net seller
$1.77M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
120.59K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−83.33K
Price / share
$14.41
Trade value
$1.20M
% of position
3.6%
4/6/2026
2.30M→2.22M
Common Stock
Direct
Shares
−37.26K
Price / share
$15.19
Trade value
$566.02K
% of position
1.7%
4/8/2026
2.22M→2.18M
Total
Net shares
−120.59K
Net value
-$1.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | S · Sale | −83.33K | $14.41 | $1.20M | 3.6% | 2.30M | 2.22M |
| Common Stock Direct | 4/8/2026 | S · Sale | −37.26K | $15.19 | $566.02K | 1.7% | 2.22M | 2.18M |
| Total | −120.59K | -$1.77M | ||||||
Derivative Transactions0
No derivative transactions reported